** Jubilant Pharmova JUBA.NS rises 4% to 942 rupees, highest in three weeks
** Drugmaker posts Q4 consol net profit of 1.54 bln rupees ($18 mln) vs year-ago loss of 586 mln rupees, which included a one time charge of 1.69 bln rupees
** Still, profit before one-time charge up 82% y/y
** Rev rises 10% y/y, driven by strong demand for co's drugs with radioactive ingredients
** JUBA was up 0.3% before results
** Volumes pick up post results, with shares traded ~3x the 30-day avg
** YTD, JUBA falls 18%
($1 = 85.6350 Indian rupees)
(Reporting by Nishit Navin in Bengaluru)